SCHEMBL8423690

SCHEMBL8423690

COC(C)(C)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
CYP2A6 P11509 3/20 0.41
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 1/20 0.39
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 2/20 0.37
HPGD P15428 2/20 0.37
CYP3A4 P08684 1/20 0.37
KEAP1 Q14145 1/20 0.37
ACP3 P15309 2/20 0.37
RAB9A P51151 1/20 0.36
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
HPRT1 P00492 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15067822 0.82 ALDH1A1 (0.40) ALDH1A1CYP2A6HSD17B10KDM4EMAPT
SCHEMBL26208769 0.82 ALDH1A1 (0.40) ALDH1A1CYP2A6HSD17B10KDM4EMAPT
SCHEMBL9015724 0.82 ALDH1A1 (0.47) ALDH1A1CYP2A6HSD17B10KDM4ETSHR
SCHEMBL28654871 0.81 ALDH1A1 (0.43) ALDH1A1CYP2A6HSD17B10KDM4EMAPT
SCHEMBL7196892 0.80 ALDH1A1 (0.41) ALDH1A1CYP2A6HSD17B10KDM4EMAPT
SCHEMBL4196250 0.80 NR1I2 (0.32) ALDH1A1KDM4ECYP1A2HPGDNR1I2
SCHEMBL29947075 0.79 MAPK1 (0.42) ALDH1A1HSD17B10KDM4ETSHRTDP1
SCHEMBL6900861 0.79 MAPK1 (0.42) ALDH1A1HSD17B10KDM4ETSHRTDP1
SCHEMBL26208770 0.79 KDM4E (0.38) ALDH1A1CYP2A6HSD17B10KDM4EMAPT
SCHEMBL547819 0.78 ALDH1A1 (0.44) ALDH1A1CYP2A6HSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230280655-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-07 US disclosed
US-8835092-B2 Resist underlayer film composition, process for forming resist underlayer film, patterning process and fullerene derivative SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-16 US disclosed
US-20110195362-A1 RESIST UNDERLAYER FILM COMPOSITION, PROCESS FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS AND FULLERENE DERIVATIVE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-08-11 US disclosed
US-20110195362-A1 RESIST UNDERLAYER FILM COMPOSITION, PROCESS FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS AND FULLERENE DERIVATIVE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-08-11 US disclosed
US-5955509-A POLY(VINYL N-HETEROCYCLE)-BLOCK-POLY(ALKYLENE OXIDE) COPOLYMERS IN MICELLE CONTAINING PHARMACEUTICAL FORMULATIONS. BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1999-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195362-A1 RESIST UNDERLAYER FILM COMPOSITION, PROCESS FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS AND FULLERENE DERIVATIVE PARG, TOP2A, FRG1 ALDH1A1 3305/4885CYP2A6 2052/4885HSD17B10 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.